Serratia Spp. Meningitis in A Child with Venticulo-Peritoneal Shunt

Year 2021, Volume: 9 Issue: 3, 140 - 143, 31.12.2021

Emine Kübra Dindar Demiray , Sevil Alkan , Mustafa Yasir Akyıldız , Özgür Ezin , Sinem Sefer

https://doi.org/10.21765/pprjournal.933565

Abstract

Serratia species are opportunistic, gram-negative, motile bacteria classified in the large family Enterobacteriaceae and differentiate from Klebsiella spp. with slow fermenting lactose and DNAase positive (1,2). One of the characteristics of Serratia bacteria that distinguishes them from other bacteria is to synthesize the red pigments, prodigiosins. It can cause nosocomial infections especcialy in newborns and patients in intensive care units. Serratia spp.; responsible for approximately 2% of nosocomial infections; has been reported as the responsible agent especially in respiratory tract infections, urinary tract infections and bacteremia. An outbreak of S. marcescens blood stream infection has been identified in patients receiving contaminated parenteral nutrition bags (2). It has been reported to cause S. marcescens meningitis, wound infections, arthritis and outbreaks in pediatric wards (3).
In this text we aimed to present a three and a half year old girl case of acute bacterial meningitis due to Serratia spp. with ventriculo-peritoneal shunt.

Keywords

ventriculo-peritoneal shunt, acute bacterial meningitis, Serratia, ventriculo-peritoneal shunt, child

Project Number

yok

Ventrikulo-peritoneal Şantlı Çocukta Serratia Spp. Menenjiti

Abstract

Supporting Institution

yok

Project Number

yok

References

• 1. https://emedicine.medscape.com/article/228495-overview [Accessed date: 10.01.2021]
• 2. Iosifidis E, Farmaki E, Nedelkopoulou N, Tsivitanidou M, Kaperoni M, Pentsoglou V, et al. Outbreak of bloodstream infections because of Serratia marcescens in a pediatric department. Am J Infect Control. 2012;40(1):11-5. doi: 10.1016/j.ajic.2011.03.020. PMID: 21856046.
• 3. Gupta N, Hocevar SN, Moulton-Meissner HA, Stevens KM, McIntyre MG, Jensen B, et al. Outbreak of Serratia marcescens bloodstream infections in patients receiving parenteral nutrition prepared by a compounding pharmacy. Clin Infect Dis. 2014;59(1):1-8. doi: 10.1093/cid/ciu218.
• 4. Levy J. Meningitis due to Serratia Margescens. Harefuah. 1952;42(7):87-8. PMID: 12999060.
• 5. Ersoz G, Uguz M, Aslan G, Horasan ES, Kaya A. Outbreak of meningitis due to Serratia marcescens after spinal anaesthesia. J Hosp Infect. 2014;87(2):122-5. doi: 10.1016/j.jhin.2014.03.004.
• 6. Campbell JR, Diacovo T, Baker CJ. Serratia marcescens meningitis in neonates. Pediatr Infect Dis J. 1992;11(10):881-6. doi: 10.1097/00006454-199210000-00015.
• 7. Hirooka TM, Fontes RB, Diniz EM, Pinto FC, Matushita H. Cerebral abscess caused by Serratia marcescens in a premature neonate. Arq Neuropsiquiatr. 2007 ;65(4A):1018-21.
• 8. Kimpen JL, Brus F, Arends JP, de Vries-Hospers HG. Successful medical treatment of multiple Serratia marcescens brain abscesses in a neonate. Eur J Pediatr. 1996 ;155(10):916. doi: 10.1007/BF02282850. PMID: 8891569.
• 9. Madide A, Smith J. Intracranial complications of Serratia marcescens infection in neonates. S Afr Med J. 2016;106(4):36-8. doi: 10.7196/SAMJ.2016.v106i4.10206. PMID: 27032843.
• 10. Theccanat G, Hirschfield L, Isenberg H. Serratia marcescens meningitis. J Clin Microbiol. 1991;29(4):822-3. doi: 10.1128/JCM.29.4.822-823.1991.
• 11. Wu YM, Hsu PC, Yang CC, Chang HJ, Ye JJ, Huang CT, et al. Serratia marcescens meningitis: epidemiology, prognostic factors and treatment outcomes. J Microbiol Immunol Infect. 2013;46(4):259-65. doi: 10.1016/j.jmii.2012.07.006.
• 12. Chang CJ, Ye JJ, Yang CC, Huang PY, Chiang PC, Lee MH. Influence of third-generation cephalosporin resistance on adult in-hospital mortality from post-neurosurgical bacterial meningitis. J Microbiol Immunol Infect. 2010;43(4):301-9.